STP
WGS icon

Science & Technology Partners’s GeneDx Holdings WGS Stock Holding History

Science & Technology Partners’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.5M Buy
241,200
+39,936
+20% +$3.64M 4.05% 11
2025
Q4 		$26.2M Sell
201,264
-22,809
-10% -$3.13M 7.28% 2
2025
Q3 		$24.1M Sell
224,073
-93,203
-29% -$10.2M 6.73% 3
2025
Q2 		$29.3M Buy
317,276
+40,635
+15% +$3.19M 7.67% 2
2025
Q1 		$24.5M Sell
276,641
-124,359
-31% -$10.8M 9.71% 1
2024
Q4 		$30.8M Buy
+401,000
New +$28M 9.36% 1

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Science & Technology Partners's WGS Position: Q1 2026 in Review

Science & Technology Partners increased its GeneDx Holdings (WGS) stake by 20% in Q1 2026, buying an estimated $3.64M and bringing the position to 241,200 shares worth $15.5M. The position accounts for 4.05% of the portfolio, ranked #11.

Science & Technology Partners first reported a position in WGS in Q4 2024 and has held it in 6 quarters since. The position peaked at $30.8M in Q4 2024. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Science & Technology Partners held 241,200 shares of GeneDx Holdings worth $15.5M as of Q1 2026.
  • Science & Technology Partners bought 39,936 GeneDx Holdings shares in Q1 2026, an estimated $3.64M.
  • GeneDx Holdings made up 4.05% of Science & Technology Partners's portfolio in Q1 2026, its #11 holding.
  • Science & Technology Partners first reported a position in GeneDx Holdings in Q4 2024 and has held it in 6 quarters since.
  • Science & Technology Partners's GeneDx Holdings position peaked at $30.8M in Q4 2024.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Science & Technology Partners's 13F filing for Q1 2026, filed 15 May 2026.